News Medical on MSN8h
MassiveFold advances protein structure prediction with efficient parallel processing
Researchers developed MassiveFold, an enhanced AlphaFold version optimized for parallel processing, which accelerates protein ...
Non-Hodgkin’s Lymphoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...
Medical Xpress21d
Antibody that reduces inflammation may serve as cardio-immunotherapy for heart failure patients
They used a therapeutic protein—called a monoclonal antibody—that blocks the formation ... with the wide availability of the most advanced single cell sequencing technologies, could scientists ...
precisionmedicineonline16h
Marengo Therapeutics Advancing Bispecific Antibody to Phase II After Positive First-in-Human Data
A Phase I study of invikafusp alfa presented at SITC provided the rationale to enroll patients with TMB-high, MSI-high, and virus-associated tumors in Phase II.
Medscape2d
Monoclonal Antibodies in Rheumatoid Arthritis
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting
Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.
Medpage Today on MSN19d
Are Norovirus Vaccines on the Horizon?
mRNA Shot A single injection of mRNA-1403 stimulated robust histo-blood group antigen-blocking antibodies and serum ... a ...
Science Daily21d
Immunotherapy blocks scarring, improves heart function in mice with heart failure
Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment ... of the most advanced single cell sequencing ...
Fred Hutch28d
First in-human HIV vaccine to induce virus-specific neutralizing antibodies
Most other HIV vaccine formulations use a single HIV Env protein as the immunogen which has different surfaces available that can distract the immune system from making antibodies binding the Env ...
Indapta Therapeutics Presents Clinical and Preclinical Data of Allogenic Natural Killer Cell Therapy at Society for Immunotherapy of Cancer Meeting
Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated cell therapies for the treatment of cancer and autoimmune diseases, today ...
Yahoo Finance22d
OmniAb to Report Third Quarter 2024 Financial Results on November 12
OmniFlic® and OmniClic® are fixed or common light-chain rats and chickens ... OmnidAb™, is an in vivo platform for the discovery of single domain antibodies based upon a human VH scaffold that ...
TMCnet4d
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
MOUNTAIN VIEW, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced ...